Cargando…
NAD(+)-Dependent Activation of Sirt1 Corrects the Phenotype in a Mouse Model of Mitochondrial Disease
Mitochondrial disorders are highly heterogeneous conditions characterized by defects of the mitochondrial respiratory chain. Pharmacological activation of mitochondrial biogenesis has been proposed as an effective means to correct the biochemical defects and ameliorate the clinical phenotype in thes...
Autores principales: | Cerutti, Raffaele, Pirinen, Eija, Lamperti, Costanza, Marchet, Silvia, Sauve, Anthony A., Li, Wei, Leoni, Valerio, Schon, Eric A., Dantzer, Françoise, Auwerx, Johan, Viscomi, Carlo, Zeviani, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051987/ https://www.ncbi.nlm.nih.gov/pubmed/24814483 http://dx.doi.org/10.1016/j.cmet.2014.04.001 |
Ejemplares similares
-
Opa1 Overexpression Ameliorates the Phenotype of Two Mitochondrial Disease Mouse Models
por: Civiletto, Gabriele, et al.
Publicado: (2015) -
In Vivo Correction of COX Deficiency by Activation of the AMPK/PGC-1α Axis
por: Viscomi, Carlo, et al.
Publicado: (2011) -
Rapamycin rescues mitochondrial myopathy via coordinated activation of autophagy and lysosomal biogenesis
por: Civiletto, Gabriele, et al.
Publicado: (2018) -
AAV9-based gene therapy partially ameliorates the clinical phenotype of a mouse model of Leigh syndrome
por: Di Meo, I, et al.
Publicado: (2017) -
Mitochondrial Neurodegeneration
por: Zeviani, Massimo, et al.
Publicado: (2022)